SEC Form 5 · accession 0001388410-19-000007
PARALLAX HEALTH SCIENCES, INC. · PRLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul R Arena
Officer — CEO, President · Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 15, 2019 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388410
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PREFERRED STOCK (SERIES C) | $0.12 | Sep 30, 2018 | A | 30,000 | A | Sep 30, 2018 | Sep 30, 2021 | COMMON STOCK | 1,250,000 | 5,030,000 | D |
| WARRANTS | $0.25 | Sep 30, 2018 | A | 15,000 | A | Sep 30, 2018 | Sep 30, 2021 | COMMON STOCK | 625,000 | 5,045,000 | D |
Explanation of responses
- F1Shares issued in exchange for $150,000 in outstanding debt owed by PRLX
- F2Warrants granted in connection with Series C Preferred Shares at 50%